[1
]
Asbestos Diseases Research Institute, Sydney, NSW, Australia; Sydney Medical School,
University of Sydney, Sydney, NSW, Australia. Electronic address: nico.vanzandwijk@sydney.edu.au.
[2
]
Northern Cancer Institute, Sydney, NSW, Australia; Sydney Medical School, University
of Sydney, Sydney, NSW, Australia.
[3
]
Asbestos Diseases Research Institute, Sydney, NSW, Australia; Chris O'Brien Lifehouse,
Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW,
Australia.
[4
]
Department of Oncology, Concord Repatriation General Hospital, Sydney, NSW, Australia.
[5
]
Chris O'Brien Lifehouse, Sydney, NSW, Australia; Sydney Medical School, University
of Sydney, Sydney, NSW, Australia.
[6
]
Asbestos Diseases Research Institute, Sydney, NSW, Australia; Sydney Medical School,
University of Sydney, Sydney, NSW, Australia.
[7
]
Department of Molecular Imaging (PET and Nuclear Medicine), Royal Prince Alfred Hospital,
Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW,
Australia.
[8
]
Department of Nuclear Medicine, Royal North Shore Hospital, Sydney, NSW, Australia;
Faculty of Health Sciences, University of Sydney, Sydney, NSW, Australia.
[9
]
Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital,
Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW,
Australia; School of Medicine, Western Sydney University, Sydney, NSW, Australia.
[10
]
Department of Cardiology, Concord Repatriation General Hospital, Sydney, NSW, Australia;
Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
[11
]
Department of Radiology, Concord Repatriation General Hospital, Sydney, NSW, Australia.
[12
]
EnGeneIC, Sydney, NSW, Australia.